Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis
- PMID: 30422678
- PMCID: PMC6519866
- DOI: 10.1164/rccm.201811-2103ED
Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis
Comment on
-
Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.Am J Respir Crit Care Med. 2019 May 15;199(10):1238-1248. doi: 10.1164/rccm.201807-1203OC. Am J Respir Crit Care Med. 2019. PMID: 30409023 Clinical Trial.
References
-
- Stahl M, Wielputz MO, Ricklefs I, Dopfer C, Barth S, Schlegtendal A, et al. Preventive inhalation of hypertonic saline in infants with cystic fibrosis (PRESIS): a randomized, double-blind, controlled study. Am J Respir Crit Care Med. 2019;199:1238–1248. - PubMed
-
- Hoo AF, Thia LP, Nguyen TT, Bush A, Chudleigh J, Lum S, et al. London Cystic Fibrosis Collaboration. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax. 2012;67:874–881. - PubMed
-
- Davies G, Stocks J, Thia LP, Hoo AF, Bush A, Aurora P, et al. London Cystic Fibrosis Collaboration (LCFC) Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient. Eur Respir J. 2017;50:1700326. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical